Arthritis drug may prevent severely ill coronavirus patients from needing life support
A small French study has found that severely ill coronavirus patients given tocilizumab, a drug used to treat rheumatoid arthritis, were less likely to be put on life support and less likely to die.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Actemra | Arthritis | Coronavirus | COVID-19 | France Health | Health | Rheumatoid Arthritis | Rheumatology | Study